Sugi Predict

Sugi Predict / Compounds / SCHEMBL19949219

SCHEMBL19949219

SCHEMBL19949219

CCCCCCCCC[C@@H](O)CCO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 1/20 0.57
▸ FFAR1 O14842 1/20 0.57
▸ PSMD14 O00487 2/20 0.55
▸ PLA2G1B P04054 2/20 0.55
▸ MMP2 P08253 2/20 0.55
▸ ATG4B Q9Y4P1 2/20 0.55
▸ HSP90AA1 P07900 1/20 0.55
▸ RAD52 P43351 1/20 0.55
▸ GPR84 Q9NQS5 6/20 0.54
▸ LMNA P02545 4/20 0.52
▸ ALDH1A1 P00352 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ CYP2D6 P10635 2/20 0.48
▸ SPHK1 Q9NYA1 1/20 0.48
▸ GMNN O75496 1/20 0.48
▸ POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL887247 1.00 FFAR4 (0.57) FFAR4FFAR1PSMD14PLA2G1BMMP2
SCHEMBL995404 1.00 FFAR4 (0.57) FFAR4FFAR1PSMD14PLA2G1BMMP2
SCHEMBL7209288 1.00 FFAR4 (0.57) FFAR4FFAR1PSMD14PLA2G1BMMP2
SCHEMBL23188459 1.00 FFAR4 (0.57) FFAR4FFAR1PSMD14PLA2G1BMMP2
SCHEMBL4553176 1.00 FFAR4 (0.57) FFAR4FFAR1PSMD14PLA2G1BMMP2
SCHEMBL23225808 1.00 FFAR4 (0.57) FFAR4FFAR1PSMD14PLA2G1BMMP2
SCHEMBL16074935 1.00 FFAR4 (0.57) FFAR4FFAR1PSMD14PLA2G1BMMP2
SCHEMBL21660117 1.00 FFAR4 (0.57) FFAR4FFAR1PSMD14PLA2G1BMMP2
SCHEMBL22910843 1.00 FFAR4 (0.57) FFAR4FFAR1PSMD14PLA2G1BMMP2
SCHEMBL609589 1.00 FFAR4 (0.57) FFAR4FFAR1PSMD14PLA2G1BMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250243143-A1 1,3-Fatty Diol Compounds And Derivatives Thereof AGAIN BIO APS (DK) 2025-07-31 — — US disclosed
US-12304883-B2 1,3-fatty diol compounds and derivatives thereof GENOMATICA, INC. (US) 2025-05-20 — — US disclosed
CN-114773160-B 1, 3-Aliphatic diol compound and derivative thereof 基因组股份公司 2025-03-07 — — CN disclosed
EP-4223765-A1 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF Genomatica, Inc. (US) 2023-08-09 — — EP disclosed
EP-3795576-B1 1,3-FATTY DIOL COMPOUNDS AND GLYCOSYLATED DERIVATIVES THEREOF GENOMATICA INC (US) 2023-06-07 — — EP disclosed
CN-114773160-A 1, 3-aliphatic diol compound and derivative thereof 基因组股份公司 2022-07-22 — — CN disclosed
CN-109890783-B 1, 3-aliphatic diol compound and derivative thereof 基因组股份公司 2022-06-14 — — CN disclosed
US-20220098133-A1 1,3-Fatty Diol Compounds And Derivatives Thereof AGAIN BIO APS (DK) 2022-03-31 — — US disclosed
US-11168046-B2 1,3-fatty diol compounds and derivatives thereof GENOMATICA, INC. (US) 2021-11-09 — — US disclosed
EP-3795576-A1 1,3-FATTY DIOL COMPOUNDS AND GLYCOSYLATED DERIVATIVES THEREOF Genomatica, Inc. (US) 2021-03-24 — — EP disclosed
US-20200385325-A1 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF GENOMATICA, INC. (US) 2020-12-10 — — US disclosed
EP-3512825-B1 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF GENOMATICA INC (US) 2020-10-21 — — EP disclosed
US-10570074-B2 1,3-fatty diol compounds and derivatives thereof GENOMATICA, INC. (US) 2020-02-25 — — US disclosed
EP-3512825-A1 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF REG Life Sciences, LLC (US) 2019-07-24 — — EP disclosed
WO-2018053202-A1 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF REG LIFE SCIENCES LLC (US) 2018-03-22 — — WO disclosed
US-20180072645-A1 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF REG LIFE SCIENCES LLC (US) 2018-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570074-B2 1,3-fatty diol compounds and derivatives thereof DGAT1, DGAT2, DSG1 FFAR4 287/4885FFAR1 115/4885PSMD14 1199/4885
US-20250243143-A1 1,3-Fatty Diol Compounds And Derivatives Thereof DGAT1, DGAT2, DSG1 FFAR4 287/4885FFAR1 115/4885PSMD14 1199/4885
US-20180072645-A1 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF DGAT1, DGAT2, DSG1 FFAR4 287/4885FFAR1 115/4885PSMD14 1199/4885
US-12304883-B2 1,3-fatty diol compounds and derivatives thereof DGAT1, DGAT2, DSG1 FFAR4 287/4885FFAR1 115/4885PSMD14 1199/4885
US-11168046-B2 1,3-fatty diol compounds and derivatives thereof DGAT1, DGAT2, DSG1 FFAR4 287/4885FFAR1 115/4885PSMD14 1199/4885
US-20200385325-A1 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF DGAT1, DGAT2, DSG1 FFAR4 287/4885FFAR1 115/4885PSMD14 1199/4885
US-20220098133-A1 1,3-Fatty Diol Compounds And Derivatives Thereof DGAT1, DGAT2, DSG1 FFAR4 287/4885FFAR1 115/4885PSMD14 1199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.